Evaluation of potential predictive biomarker for cetuximab in a panel of colorectal cancer patient-derived xenografts (PDX). (December 2016) - Rivera, M.; Hoffmann, J.; Wulf-Goldenberg, A.; Schlag, P.M.; Merk, J.; Walther, W.; Fichtner, I.